U.S. market Closed. Opens in 4 hours 43 minutes

HZNP | Horizon Therapeutics Public Limited Company Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue3.63B3.23B2.20B1.30B1.21B1.06B981.12M757.04M296.95M74.02M19.63M6.93M2.38MN/AN/A
Cost of Revenue920.20M794.51M532.70M362.18M422.32M546.27M393.27M219.50M78.75M14.62M12.66M7.27M4.26MN/AN/A
Gross Profit2.71B2.43B1.67B937.85M785.25M509.96M587.85M537.54M218.20M59.39M6.97M-340.00K-1.89MN/AN/A
Operating Expenses1.98B1.88B1.18B800.28M775.25M902.33M669.01M482.17M226.69M102.25M85.84M50.68M41.87M18.79M26.87M
Selling, General & Admin1.54B1.45B973.23M697.11M692.49M677.36M608.31M440.31M209.23M92.16M69.00M35.32M24.17M7.89M4.57M
Research & Development437.96M431.99M209.36M103.17M82.76M224.96M60.71M41.87M17.46M10.08M16.84M15.36M17.70M10.89M22.30M
Other Operating Expenses-5.57M1.79M3.39M-944.00K346.00K588.00K6.70M-10.29M-11.25MN/A-56.00KN/AN/AN/AN/A
Operating Income617.41M543.13M490.03M126.61M2.39M-392.37M-147.17M55.37M-8.49M-42.85M-78.87M-120.64M-43.75M-18.79M-26.87M
Other Expenses / Income-90.48M-80.30M-88.38M-146.84M-121.54M-120.91M-80.92M-188.08M-261.20M-107.27M-14.09M-76.93M16.03M478.00K-503.00K
Before Tax Income526.94M462.83M401.64M-20.22M-119.15M-513.27M-228.09M-132.71M-269.69M-150.13M-92.97M-127.95M-27.73M-18.31M-27.37M
Income Tax Expenses5.45M-71.66M11.85M-593.24M-44.96M-102.75M-61.25M-172.24M-6.08M-1.12M-5.17M-14.68M-660.00K1.71M1.03M
Net Income521.48M534.49M389.80M573.02M-74.19M-410.53M-166.83M39.53M-263.60M-149.00M-87.79M-113.27M-27.07M-20.50M-27.90M
Interest Expenses83.71M81.06M59.62M87.09M121.69M126.52M86.61M69.90M23.83M39.18M14.53MN/A3.05M2.21M869.00K
Basic Shares Outstanding229.11M225.55M215.31M205.22M166.16M163.12M160.70M148.79M83.75M63.66M38.87M9.01M1.50M418.52K1.50M
Diluted Shares Outstanding235.24M235.68M215.31M205.22M166.16M163.12M160.70M155.92M83.75M63.66M38.87M9.01M1.50M418.52K1.50M
EBITDA1.11B909.04M767.98M373.79M286.08M-108.37M147.37M55.37M-8.49M-42.85M-73.39MN/A-39.93M-19.19M-26.33M
EBITDA Margin30.71%28.17%34.90%28.75%23.69%-10.26%15.02%7.31%-2.86%-57.90%-373.83%0.00%-1,680.43%0.00%0.00%
EBIT610.64M543.89M461.26M66.86M2.55M-386.75M-141.47M-62.81M-245.86M-110.95M-78.44M-127.95M-24.67M-16.57M-26.00M
EBIT Margin16.83%16.86%20.96%5.14%0.21%-36.62%-14.42%-8.30%-82.79%-149.90%-399.55%-1,847.09%-1,038.43%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙